Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Pharmacokinetics of the protease inhibitor indinavir in human immunodeficiency virus type 1-infected children.

Burger DM, van Rossum AM, Hugen PW, Suur MH, Hartwig NG, Geelen SP, Scherpbier HJ, Hoetelmans RM, Vulto AG, de Groot R; Dutch Study Group for Children with HIV-1 Infection.

Antimicrob Agents Chemother. 2001 Mar;45(3):701-5.

2.

Clinical and virologic response to combination treatment with indinavir, zidovudine, and lamivudine in children with human immunodeficiency virus-1 infection: a multicenter study in the Netherlands. On behalf of the Dutch Study Group for Children with HIV-1 infections.

van Rossum AM, Niesters HG, Geelen SP, Scherpbier HJ, Hartwig NG, Weemaes CM, Veerman AJ, Suur MH, de Graeff-Meeder ER, Slieker WA, Hop WC, Osterhaus AD, Burger DM, De Groot R.

J Pediatr. 2000 Jun;136(6):780-8.

PMID:
10839877
3.

Early recovery of CD4+ T lymphocytes in children on highly active antiretroviral therapy. Dutch study group for children with HIV infections.

Cohen Stuart JW, Slieker WA, Rijkers GT, Noest A, Boucher CA, Suur MH, de Boer R, Geelen SP, Scherpbier HJ, Hartwig NG, Hooijkaas H, Roos MT, de Graeff-Meeder B, de Groot R.

AIDS. 1998 Nov 12;12(16):2155-9.

PMID:
9833856
4.

Informed consent, parental awareness, and reasons for participating in a randomised controlled study.

van Stuijvenberg M, Suur MH, de Vos S, Tjiang GC, Steyerberg EW, Derksen-Lubsen G, Moll HA.

Arch Dis Child. 1998 Aug;79(2):120-5.

5.

Complement activation in relation to capillary leakage in children with septic shock and purpura.

Hazelzet JA, de Groot R, van Mierlo G, Joosten KF, van der Voort E, Eerenberg A, Suur MH, Hop WC, Hack CE.

Infect Immun. 1998 Nov;66(11):5350-6.

6.

Interleukin 12 levels during the initial phase of septic shock with purpura in children: relation to severity of disease.

Hazelzet JA, Kornelisse RF, van der Pouw Kraan TC, Joosten KF, van der Voort E, van Mierlo G, Suur MH, Hop WC, de Groot R, Hack CE.

Cytokine. 1997 Sep;9(9):711-6.

PMID:
9325021
7.

Meningococcal septic shock in children: clinical and laboratory features, outcome, and development of a prognostic score.

Kornelisse RF, Hazelzet JA, Hop WC, Spanjaard L, Suur MH, van der Voort E, de Groot R.

Clin Infect Dis. 1997 Sep;25(3):640-6.

PMID:
9314453
8.

Intrathecal production of interleukin-12 and gamma interferon in patients with bacterial meningitis.

Kornelisse RF, Hack CE, Savelkoul HF, van der Pouw Kraan TC, Hop WC, van Mierlo G, Suur MH, Neijens HJ, de Groot R.

Infect Immun. 1997 Mar;65(3):877-81.

9.

Interleukin-10 and soluble tumor necrosis factor receptors in cerebrospinal fluid of children with bacterial meningitis.

Kornelisse RF, Savelkoul HF, Mulder PH, Suur MH, van der Straaten PJ, van der Heijden AJ, Sukhai RN, Hählen K, Neijens HJ, de Groot R.

J Infect Dis. 1996 Jun;173(6):1498-502.

PMID:
8648229
10.

The relationship between plasminogen activator inhibitor-1 and proinflammatory and counterinflammatory mediators in children with meningococcal septic shock.

Kornelisse RF, Hazelzet JA, Savelkoul HF, Hop WC, Suur MH, Borsboom AN, Risseeuw-Appel IM, van der Voort E, de Groot R.

J Infect Dis. 1996 May;173(5):1148-56.

PMID:
8627066

Supplemental Content

Support Center